Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults
Sponsor: London School of Hygiene and Tropical Medicine
Summary
Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
Official title: Intramuscular Tranexamic Acid for the Treatment of Symptomatic Mild Traumatic Brain Injury in Older Adults: a Randomised, Double-blind, Placebo-controlled Trial
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5000
Start Date
2021-04-18
Completion Date
2028-01-31
Last Updated
2026-03-12
Healthy Volunteers
No
Conditions
Interventions
Tranexamic Acid 500 MG
given once as an intramuscular injection
Locations (2)
The Royal London Hospital
London, London, United Kingdom
St George's Hospital
London, London, United Kingdom